Litigation Details for United HealthCare Services, Inc. v. Gilead Sciences, Inc. (N.D. Cal. 2021)
✉ Email this page to a colleague
United HealthCare Services, Inc. v. Gilead Sciences, Inc. (N.D. Cal. 2021)
Docket | ⤷ Try a Trial | Date Filed | 2021-11-28 |
Court | District Court, N.D. California | Date Terminated | |
Cause | 15:1 Antitrust Litigation | Assigned To | Edward Milton Chen |
Jury Demand | Plaintiff | Referred To | |
Patents | 6,043,230; 6,642,245; 6,703,396; 8,592,397; 8,716,264; 9,457,036 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in United HealthCare Services, Inc. v. Gilead Sciences, Inc.
Biologic Drugs cited in United HealthCare Services, Inc. v. Gilead Sciences, Inc.
Details for United HealthCare Services, Inc. v. Gilead Sciences, Inc. (N.D. Cal. 2021)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2021-10-19 | 1 | 5,922,695 (the “’695 Patent”); 5,977,089 (the “’089 Patent”); and 6,043,230 (the “’230 Patent”). These three…by the TDF Patents (the ’695 patent, the ’089 patent, the ’230 patent, and the ’946 patent), which expired…Enantiomer Patents as well as its four TDF Patents and as to BMS’s EFV Patents, asserting the patents were …Ancillary Patent Portfolio 79. Gilead’s Viread patent portfolio includes U.S. Patent Nos. 5,922,695…Collectively, the four patents are referred to herein as the “TDF Patents.” Gilead obtained patent and pediatric | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |